All News BRAZIL IBRX

Index

IBX

BRIBXXINDM15

Delayed Sao Paulo 10:15:30 29/05/2024 pm IST 5-day change 1st Jan Change
51,952 PTS -0.58% Intraday chart for BRAZIL IBRX -3.31% -7.97%
ImmunityBio Shares Rise After Completion of Drug Substance Manufacturing for Cancer Treatment MT
Social Buzz: Wallstreetbets Stocks Mixed Pre-Bell Monday; Palantir to Advance, Trump Media & Technology Group to Decline MT
Social Buzz: Wallstreetbets Stocks Mixed Pre-Bell Friday; ImmunityBio to Advance, Boeing to Decline MT
Social Buzz: Wallstreetbets Stocks Mostly Lower Premarket Tuesday; MicroStrategy, Tesla to Decline MT
Social Buzz: Wallstreetbets Stocks Mostly Higher Premarket Monday; Tesla, ImmunityBio to Advance MT
ImmunityBio Gaining in Tuesday Pre-Market after FDA Approval for Anktiva-Bacterium Combination for Bladder Cancer MT
Upcoming Big Tech Earnings Buoy Exchange-Traded Funds, Equity Futures Pre-Bell Tuesday MT
Top Premarket Gainers MT
ImmunityBio Files Mixed Shelf MT
North American Morning Briefing : Markets Steady -2- DJ
North American Morning Briefing : Stock Futures -2- DJ
ImmunityBio Says Cancer Vaccine Trial Moving to Controlled Phase MT
US Equity Markets Close Lower Tuesday Ahead of Fed Meeting Minutes MT
Sector Update: Health Care Stocks Gain Late Afternoon MT
Sector Update: Health Care Stocks Rise Tuesday Afternoon MT
ImmunityBio Secures $320 Million Investment From Oberland Capital MT
Sector Update: Health Care MT
Top Stories at Midday: US Construction Spending Up 0.4% in November; Avangrid-PNM Resources Deal Terminated; Terreno Realty Sells California Property for $15.9 Million; ImmunityBio Secures $320 Million Investment MT
Indices: Focus on tech, Brazil and China Our Logo
Sector Update: Health Care Stocks Softer Thursday Afternoon MT
ImmunityBio Shares Rise After FDA Accepted Resubmitted Biologics License Application for N-803 Plus BCG MT
ImmunityBio Says FDA Accepted Resubmitted Biologics License Application for N-803 Plus BCG MT
Sector Update: Health Care Stocks Softer Late Afternoon MT
Sector Update: Health Care Stocks Mixed in Monday Afternoon Trading MT
ImmunityBio Resubmits Biologics License Application for Bladder Cancer Combination Therapy MT
ImmunityBio Secures $40 Million Equity Financing MT
ImmunityBio Says Study Indicates N-803 May Contribute to Tumor Regression in Head and Neck Cancers MT
Wall Street Set to Open Mixed; Jobless Claims Higher Than Expected, PPI Lower Than Expected MT
US Futures Trends Mostly Lower Ahead of Jobs Report, Producer Price Index Data MT
Top Premarket Decliners MT
ImmunityBio Submits License Application to US FDA for N-803 Bladder Cancer Treatment MT
Sector Update: Health Care Stocks Drop Late Wednesday MT
Sector Update: Health Care Stocks Lower in Midday Trading MT
ImmunityBio to Raise $50 Million From Shares, Warrants Offering; Stock Falls MT
ImmunityBio Reports Positive Data From Metastatic Pancreatic Cancer Study MT
ImmunityBio to Get $157 Million Financing from Nant, Institutional Investor; Shares Rise MT
ImmunityBio Files Biologics License Application With FDA for Bladder Cancer Combination Immunotherapy MT
ImmunityBio Enrolls First Subjects in Lung Cancer Master Protocol Trial of Anktiva MT
Immunitybio Says Stimulated Natural Killer Cells Led to Complete Response in Leukemia Trial MT
Sector Update: Health Care Stocks Stabilize in Afternoon Trading MT
Sector Update: Health Care Stocks Gaining This Afternoon MT
Sector Update: Health Care MT
Sector Update: Health Care Stocks Gain Pre-Bell Tuesday MT
ImmunityBio Reports 'Positive' Results from Late-Stage Bladder Cancer Trial -- Shares Jump in Pre-Market Trading MT
Health Care Stocks Edge Higher Pre-Bell Tuesday MT
Detailed heatmap